Fullen Douglas R, Zhu Weijian, Thomas Dafydd, Su Lyndon D
Department of Pathology, University of Michigan Medical Center, 1301 Catherine, Ann Arbor, MI 48109-0602, USA.
J Cutan Pathol. 2005 Nov;32(10):680-4. doi: 10.1111/j.0303-6987.2005.00403.x.
Telomerase plays a role in the immortalization of cells and carcinogenesis. Previous studies have yielded conflicting results on whether human telomerase RNA (hTER) expression differs in nevi, atypical nevi and melanomas using polymerase chain reaction-based telomeric repeat amplification protocol or in situ hybridization assays. The aim of this study was to evaluate human telomerase reverse transcriptase (hTERT) staining in melanocytic lesions on paraffin-embedded tissues.
Paraffin-embedded sections from 12 acquired nevi, seven dysplastic nevi, 11 Spitz nevi, eight primary invasive melanomas, and three metastatic melanomas were studied for staining intensity (0-3+) and percentage of labeled cells with anti-hTERT.
hTERT staining was observed in most cells (>75%), in all but three lesions, and was of greater intensity in the nucleus, especially the nucleolus, compared with the cytoplasm. Spitz nevi tended to have weaker hTERT staining (mean = 1.7) compared with acquired nevi (mean = 2.2), dysplastic nevi (mean = 2.4), primary melanomas (mean = 2.4), or metastatic melanomas (mean = 3).
Although telomerase activity was weaker in Spitz nevi, there was overlap with other nevi and primary invasive melanomas in our small series. Thus, hTERT expression does not appear to be a reliable adjunct to the histological diagnosis of primary melanocytic lesions.
端粒酶在细胞永生化和致癌过程中发挥作用。先前的研究使用基于聚合酶链反应的端粒重复序列扩增协议或原位杂交检测,在痣、非典型痣和黑色素瘤中人类端粒酶RNA(hTER)表达是否存在差异方面得出了相互矛盾的结果。本研究的目的是评估石蜡包埋组织中黑素细胞病变的人类端粒酶逆转录酶(hTERT)染色情况。
对12例获得性痣、7例发育异常痣、11例Spitz痣、8例原发性浸润性黑色素瘤和3例转移性黑色素瘤的石蜡包埋切片进行抗hTERT染色强度(0-3+)和标记细胞百分比的研究。
除3个病变外,在所有病变的大多数细胞(>75%)中均观察到hTERT染色,与细胞质相比,细胞核尤其是核仁中的染色强度更大。与获得性痣(平均=2.2)、发育异常痣(平均=2.4)、原发性黑色素瘤(平均=2.4)或转移性黑色素瘤(平均=3)相比,Spitz痣的hTERT染色往往较弱(平均=1.7)。
虽然Spitz痣中的端粒酶活性较弱,但在我们的小样本系列中,它与其他痣和原发性浸润性黑色素瘤存在重叠。因此,hTERT表达似乎不是原发性黑素细胞病变组织学诊断的可靠辅助手段。